Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Initiation
Health Catalyst initiated with a Buy at Stifel » 04:50
06/18/20
06/18
04:50
06/18/20
04:50
HCAT

Health Catalyst

$29.71 /

+0.04 (+0.13%)

Stifel analyst David…

Stifel analyst David Grossman initiated coverage of Health Catalyst with a Buy rating and $36 price target. Hospitals are under increasing pressure to provide better clinical outcomes at lower costs and Health Catalyst provides large health systems software and the professional services expertise, which enables the company to improve clinical outcomes and financial performance, Grossman tells investors in a research note. Despite some near-term uncertainty due to COVID-19,Health Catalyst is a 20% grower with expanding margins, says the analyst.

ShowHide Related Items >><<
HCAT Health Catalyst
$29.71 /

+0.04 (+0.13%)

HCAT Health Catalyst
$29.71 /

+0.04 (+0.13%)

06/15/20 Evercore ISI
Health Catalyst assumed with an Outperform at Evercore ISI
05/27/20 Piper Sandler
Piper bullish on post pandemic opportunities for Health Catalyst
05/15/20
Fly Intel: Top five analyst initiations
05/15/20 Guggenheim
Guggenheim sees Health Catalyst at attractive entry point, starts at Buy
HCAT Health Catalyst
$29.71 /

+0.04 (+0.13%)

HCAT Health Catalyst
$29.71 /

+0.04 (+0.13%)

Initiation
Health Catalyst assumed with an Outperform at Evercore ISI » 09:11
06/15/20
06/15
09:11
06/15/20
09:11
HCAT

Health Catalyst

$27.23 /

-0.14 (-0.51%)

Evercore ISI analyst…

Evercore ISI analyst Elizabeth Anderson assumed coverage of Health Catalyst with an Outperform rating and $32 price target.

ShowHide Related Items >><<
HCAT Health Catalyst
$27.23 /

-0.14 (-0.51%)

HCAT Health Catalyst
$27.23 /

-0.14 (-0.51%)

05/27/20 Piper Sandler
Piper bullish on post pandemic opportunities for Health Catalyst
05/15/20
Fly Intel: Top five analyst initiations
05/15/20 Guggenheim
Guggenheim sees Health Catalyst at attractive entry point, starts at Buy
05/15/20 Guggenheim
Health Catalyst initiated with a Buy at Guggenheim
HCAT Health Catalyst
$27.23 /

-0.14 (-0.51%)

HCAT Health Catalyst
$27.23 /

-0.14 (-0.51%)

Conference/Events
Goldman Sachs to hold a virtual conference » 08:47
06/11/20
06/11
08:47
06/11/20
08:47
HUM

Humana

$392.51 /

+1.51 (+0.39%)

, DTIL

Precision BioSciences

$8.30 /

-0.31 (-3.60%)

, CHNG

Change Healthcare

$11.85 /

-0.37 (-3.03%)

, ALKS

Alkermes

$16.77 /

-0.51 (-2.95%)

, ALNY

Alnylam

$129.96 /

+0.09 (+0.07%)

, HCAT

Health Catalyst

$28.79 /

+0.1 (+0.35%)

, KLDO

Kaleido Biosciences

$7.44 /

-0.155 (-2.04%)

, ZEAL

Zealand Pharma

$39.08 /

+0.48 (+1.24%)

, GOSS

Gossamer Bio

$12.38 /

-0.23 (-1.82%)

, MRNA

Moderna

$59.88 /

+1.58 (+2.71%)

, ORTX

Orchard Therapeutics

$7.99 /

+0.23 (+2.96%)

, BMY

Bristol-Myers

$60.15 /

-0.75 (-1.23%)

, ADVM

Adverum Biotechnologies

$23.85 /

+0.44 (+1.88%)

, BCYC

Bicycle Therapeutics

$17.35 /

+0.15 (+0.87%)

, ESPR

Esperion

$46.64 /

-1.01 (-2.12%)

, PHAT

Phathom Pharmaceuticals

$50.33 /

-1.45 (-2.80%)

, INSP

Inspire Medical

$85.53 /

-3.11 (-3.51%)

, UBX

Unity Biotechnology

$8.88 /

+0.32 (+3.74%)

, PHG

Philips

$46.76 /

-0.39 (-0.83%)

, ATRA

Atara Biotherapeutics

$9.91 /

-0.455 (-4.39%)

41st Annual Global…

41st Annual Global Healthcare Virtual Conference will be held on June 9-11. Webcast Link

ShowHide Related Items >><<
ZEAL Zealand Pharma
$39.08 /

+0.48 (+1.24%)

UBX Unity Biotechnology
$8.88 /

+0.32 (+3.74%)

PHG Philips
$46.76 /

-0.39 (-0.83%)

PHAT Phathom Pharmaceuticals
$50.33 /

-1.45 (-2.80%)

ORTX Orchard Therapeutics
$7.99 /

+0.23 (+2.96%)

MRNA Moderna
$59.88 /

+1.58 (+2.71%)

KLDO Kaleido Biosciences
$7.44 /

-0.155 (-2.04%)

INSP Inspire Medical
$85.53 /

-3.11 (-3.51%)

HUM Humana
$392.51 /

+1.51 (+0.39%)

HCAT Health Catalyst
$28.79 /

+0.1 (+0.35%)

GOSS Gossamer Bio
$12.38 /

-0.23 (-1.82%)

ESPR Esperion
$46.64 /

-1.01 (-2.12%)

DTIL Precision BioSciences
$8.30 /

-0.31 (-3.60%)

CHNG Change Healthcare
$11.85 /

-0.37 (-3.03%)

BMY Bristol-Myers
$60.15 /

-0.75 (-1.23%)

BCYC Bicycle Therapeutics
$17.35 /

+0.15 (+0.87%)

ATRA Atara Biotherapeutics
$9.91 /

-0.455 (-4.39%)

ALNY Alnylam
$129.96 /

+0.09 (+0.07%)

ALKS Alkermes
$16.77 /

-0.51 (-2.95%)

ADVM Adverum Biotechnologies
$23.85 /

+0.44 (+1.88%)

HUM Humana
$392.51 /

+1.51 (+0.39%)

06/05/20 Goldman Sachs
Humana initiated with a Buy at Goldman Sachs
06/01/20 Stephens
Molina Healthcare price target raised to $215 from $202 at Stephens
05/21/20 SunTrust
SunTrust raises price targets across select Healthcare Services names
05/04/20 Mizuho
Humana price target raised to $420 from $405 at Mizuho
DTIL Precision BioSciences
$8.30 /

-0.31 (-3.60%)

05/18/20 H.C. Wainwright
Precision BioSciences could have 'significant upside,' says H.C. Wainwright
04/02/20 Goldman Sachs
Precision BioSciences downgraded to Neutral from Buy at Goldman Sachs
04/02/20 Goldman Sachs
Precision BioSciences downgraded to Neutral from Buy at Goldman Sachs
03/04/20 Stifel
Precision BioSciences initiated with a Buy at Stifel
CHNG Change Healthcare
$11.85 /

-0.37 (-3.03%)

06/10/20 KeyBanc
Inovalon displaces Change Healthcare in Priority Health deal, says KeyBanc
06/09/20 Piper Sandler
Piper Sandler says buy Change Healthcare, sell Inovalon
04/13/20 SVB Leerink
Change Healthcare initiated with an Outperform at SVB Leerink
03/26/20 Cowen
Cowen sees three healthcare IT names poised for rebound
ALKS Alkermes
$16.77 /

-0.51 (-2.95%)

04/30/20 H.C. Wainwright
Alkermes price target lowered to $23 from $25 at H.C. Wainwright
04/29/20 Piper Sandler
Alkermes price target lowered to $21 from $22 at Piper Sandler
04/29/20 Stifel
Alkermes price target lowered to $17 from $20 at Stifel
02/14/20 JPMorgan
JPMorgan downgrades Alkermes to Neutral into 'relatively quiet' 2020
ALNY Alnylam
$129.96 /

+0.09 (+0.07%)

06/08/20 Cantor Fitzgerald
Alnylam lumasiran data reinforces confidence in efficacy, says Cantor Fitzgerald
06/07/20 Stifel
No surprises in 'positive' Alnylan Lumasiran ILLUMINATE-A data, says Stifel
05/12/20 RBC Capital
Alnylam initiated with a Sector Perform at RBC Capital
05/07/20 Oppenheimer
Alnylam price target raised to $162 from $140 at Oppenheimer
HCAT Health Catalyst
$28.79 /

+0.1 (+0.35%)

05/27/20 Piper Sandler
Piper bullish on post pandemic opportunities for Health Catalyst
05/15/20
Fly Intel: Top five analyst initiations
05/15/20 Guggenheim
Guggenheim sees Health Catalyst at attractive entry point, starts at Buy
05/15/20 Guggenheim
Health Catalyst initiated with a Buy at Guggenheim
KLDO Kaleido Biosciences
$7.44 /

-0.155 (-2.04%)

05/21/20 Morgan Stanley
Morgan Stanley downgrades Kaleido to Equal Weight amid delays for key programs
05/21/20 Morgan Stanley
Kaleido downgraded to Equal Weight from Overweight at Morgan Stanley
ZEAL Zealand Pharma
$39.08 /

+0.48 (+1.24%)

03/10/20 Morgan Stanley
Zealand Pharma EPS estimates cut at Morgan Stanley
11/19/19 Jefferies
Zealand Pharma downgraded to Hold from Buy at Jefferies
11/15/19 Needham
Zealand Pharma price target raised to $42 from $32 at Needham
10/15/19
Fly Intel: Top five analyst upgrades
GOSS Gossamer Bio
$12.38 /

-0.23 (-1.82%)

05/29/20 Piper Sandler
Piper says Gossamer's GB1275 well tolerated, early activity signs 'promising'
05/20/20 SVB Leerink
Gossamer Bio price target raised to $36 from $27 at SVB Leerink
04/22/20 Piper Sandler
Gossamer Bio initiated with an Overweight at Piper Sandler
02/27/20 Barclays
Gossamer Bio initiated with an Overweight at Barclays
MRNA Moderna
$59.88 /

+1.58 (+2.71%)

06/08/20 Barclays
Moderna initiated with an Overweight at Barclays
06/02/20 Piper Sandler
Piper reiterates Overweight rating, $100 target for Moderna after Science Day
06/02/20 BofA
Moderna price target lowered to $75 from $80 at BofA
06/01/20 Goldman Sachs
Goldman keeps $105 target after Moderna COVID vaccine moves to Phase 2
ORTX Orchard Therapeutics
$7.99 /

+0.23 (+2.96%)

05/22/20 JPMorgan
Orchard Therapeutics price target lowered to $17 from $26 at JPMorgan
09/17/19
Fly Intel: Top five analyst initiations
09/17/19
Guggenheim bullish on Orchard Therapeutics, initiates with a Buy
09/17/19 Guggenheim
Orchard Therapeutics initiated with a Buy at Guggenheim
BMY Bristol-Myers
$60.15 /

-0.75 (-1.23%)

06/08/20 Bernstein
Gilead, AstraZeneca merger would make sense on economic basis, says Bernstein
06/02/20 Credit Suisse
Arena Pharmaceuticals price target raised to $87 from $77 at Credit Suisse
06/02/20 Cantor Fitzgerald
Arena Pharmaceuticals price target raised to $88 from $68 at Cantor Fitzgerald
06/02/20 Oppenheimer
Ayala Pharmaceuticals initiated with an Outperform at Oppenheimer
ADVM Adverum Biotechnologies
$23.85 /

+0.44 (+1.88%)

05/29/20 Piper Sandler
Adverum Biotechnologies price target raised to $25 from $20 at Piper Sandler
05/12/20 RBC Capital
Adverum Biotechnologies initiated with an Outperform at RBC Capital
05/05/20 SunTrust
Adverum Biotechnologies upgraded to Buy from Hold at SunTrust
05/05/20 SunTrust
Adverum Biotechnologies upgraded to Buy from Hold at SunTrust
BCYC Bicycle Therapeutics
$17.35 /

+0.15 (+0.87%)

04/17/20
Fly Intel: Top five analyst initiations
04/17/20 H.C. Wainwright
Bicycle Therapeutics initiated with a Buy at H.C. Wainwright
04/07/20 Piper Sandler
Bicycle Therapeutics' timelines to be impacted by COVID-19, says Piper Sandler
02/25/20 Piper Sandler
Bicycle Therapeutics price target raised to $30 from $20 at Piper Sandler
ESPR Esperion
$46.64 /

-1.01 (-2.12%)

05/07/20 Citi
Esperion price target raised to $56 from $46 at Citi
04/20/20 JMP Securities
JMP reiterates $191 price target on Esperion after Japan partnership
04/16/20 Northland
Esperion price target lowered to $42 from $60 at Northland
04/01/20
Fly Intel: Top five analyst initiations
PHAT Phathom Pharmaceuticals
$50.33 /

-1.45 (-2.80%)

11/19/19 Evercore ISI
Phathom Pharmaceuticals initiated with an Outperform at Evercore ISI
11/19/19
Fly Intel: Top five analyst initiations
11/19/19 Needham
Phathom Pharmaceuticals initiated with a Buy at Needham
11/19/19 Jefferies
Phathom Pharmaceuticals initiated with a Buy at Jefferies
INSP Inspire Medical
$85.53 /

-3.11 (-3.51%)

05/26/20 Wells Fargo
Inspire Medical price target raised to $95 from $81 at Wells Fargo
05/18/20
Fly Intel: Top five analyst initiations
05/18/20 Lake Street
Inspire Medical initiated with a Buy at Lake Street
05/06/20 Guggenheim
Inspire Medical price target raised to $90 from $80 at Guggenheim
UBX Unity Biotechnology
$8.88 /

+0.32 (+3.74%)

12/13/19
Unity Biotechnology management to meet with Mizuho
12/12/19 Cantor Fitzgerald
Unity Biotechnology assumed with an Overweight at Cantor Fitzgerald
PHG Philips
$46.76 /

-0.39 (-0.83%)

04/22/20 Morgan Stanley
Philips price target lowered to EUR 45 from EUR 50 at Morgan Stanley
04/21/20 JPMorgan
Philips price target raised to EUR 36.80 from EUR 33.90 at JPMorgan
04/07/20 JPMorgan
Philips price target lowered to EUR 33.90 from EUR 43.10 at JPMorgan
03/24/20 DZ Bank
Philips upgraded to Buy from Hold at DZ Bank
ATRA Atara Biotherapeutics
$9.91 /

-0.455 (-4.39%)

05/22/20 Mizuho
Atara multiple sclerosis data looks 'awesome' at first glance, says Mizuho
04/23/20 Citi
Atara Biotherapeutics upgraded to Buy on valuation at Citi
04/23/20 Citi
Atara Biotherapeutics upgraded to Buy from Neutral at Citi
11/08/19 JPMorgan
Atara Biotherapeutics downgraded to on lack of catalysts at JPMorgan
ZEAL Zealand Pharma
$39.08 /

+0.48 (+1.24%)

UBX Unity Biotechnology
$8.88 /

+0.32 (+3.74%)

PHG Philips
$46.76 /

-0.39 (-0.83%)

PHAT Phathom Pharmaceuticals
$50.33 /

-1.45 (-2.80%)

ORTX Orchard Therapeutics
$7.99 /

+0.23 (+2.96%)

MRNA Moderna
$59.88 /

+1.58 (+2.71%)

KLDO Kaleido Biosciences
$7.44 /

-0.155 (-2.04%)

INSP Inspire Medical
$85.53 /

-3.11 (-3.51%)

HUM Humana
$392.51 /

+1.51 (+0.39%)

HCAT Health Catalyst
$28.79 /

+0.1 (+0.35%)

GOSS Gossamer Bio
$12.38 /

-0.23 (-1.82%)

ESPR Esperion
$46.64 /

-1.01 (-2.12%)

DTIL Precision BioSciences
$8.30 /

-0.31 (-3.60%)

CHNG Change Healthcare
$11.85 /

-0.37 (-3.03%)

BMY Bristol-Myers
$60.15 /

-0.75 (-1.23%)

BCYC Bicycle Therapeutics
$17.35 /

+0.15 (+0.87%)

ATRA Atara Biotherapeutics
$9.91 /

-0.455 (-4.39%)

ALNY Alnylam
$129.96 /

+0.09 (+0.07%)

ALKS Alkermes
$16.77 /

-0.51 (-2.95%)

ADVM Adverum Biotechnologies
$23.85 /

+0.44 (+1.88%)

PHG Philips
$46.76 /

-0.39 (-0.83%)

MRNA Moderna
$59.88 /

+1.58 (+2.71%)

INSP Inspire Medical
$85.53 /

-3.11 (-3.51%)

HUM Humana
$392.51 /

+1.51 (+0.39%)

CHNG Change Healthcare
$11.85 /

-0.37 (-3.03%)

BMY Bristol-Myers
$60.15 /

-0.75 (-1.23%)

ALNY Alnylam
$129.96 /

+0.09 (+0.07%)

ALKS Alkermes
$16.77 /

-0.51 (-2.95%)

PHG Philips
$46.76 /

-0.39 (-0.83%)

MRNA Moderna
$59.88 /

+1.58 (+2.71%)

KLDO Kaleido Biosciences
$7.44 /

-0.155 (-2.04%)

INSP Inspire Medical
$85.53 /

-3.11 (-3.51%)

HUM Humana
$392.51 /

+1.51 (+0.39%)

HCAT Health Catalyst
$28.79 /

+0.1 (+0.35%)

GOSS Gossamer Bio
$12.38 /

-0.23 (-1.82%)

DTIL Precision BioSciences
$8.30 /

-0.31 (-3.60%)

CHNG Change Healthcare
$11.85 /

-0.37 (-3.03%)

BMY Bristol-Myers
$60.15 /

-0.75 (-1.23%)

BCYC Bicycle Therapeutics
$17.35 /

+0.15 (+0.87%)

ALKS Alkermes
$16.77 /

-0.51 (-2.95%)

ADVM Adverum Biotechnologies
$23.85 /

+0.44 (+1.88%)

PHAT Phathom Pharmaceuticals
$50.33 /

-1.45 (-2.80%)

ORTX Orchard Therapeutics
$7.99 /

+0.23 (+2.96%)

MRNA Moderna
$59.88 /

+1.58 (+2.71%)

HUM Humana
$392.51 /

+1.51 (+0.39%)

ESPR Esperion
$46.64 /

-1.01 (-2.12%)

CHNG Change Healthcare
$11.85 /

-0.37 (-3.03%)

BMY Bristol-Myers
$60.15 /

-0.75 (-1.23%)

Over a month ago
Conference/Events
Health Catalyst management to meet virtually with Cantor Fitzgerald » 04:55
06/03/20
06/03
04:55
06/03/20
04:55
HCAT

Health Catalyst

$27.26 /

+0.46 (+1.72%)

Virtual Meeting to be…

Virtual Meeting to be held on June 3 hosted by Cantor Fitzgerald.

ShowHide Related Items >><<
HCAT Health Catalyst
$27.26 /

+0.46 (+1.72%)

HCAT Health Catalyst
$27.26 /

+0.46 (+1.72%)

05/27/20 Piper Sandler
Piper bullish on post pandemic opportunities for Health Catalyst
05/15/20
Fly Intel: Top five analyst initiations
05/15/20 Guggenheim
Guggenheim sees Health Catalyst at attractive entry point, starts at Buy
05/15/20 Guggenheim
Health Catalyst initiated with a Buy at Guggenheim
HCAT Health Catalyst
$27.26 /

+0.46 (+1.72%)

HCAT Health Catalyst
$27.26 /

+0.46 (+1.72%)

Conference/Events
Health Catalyst management to meet virtually with Cantor Fitzgerald » 07:44
06/02/20
06/02
07:44
06/02/20
07:44
HCAT

Health Catalyst

$26.80 /

-0.34 (-1.25%)

Virtual Meeting to be…

Virtual Meeting to be held on June 3 hosted by Cantor Fitzgerald.

ShowHide Related Items >><<
HCAT Health Catalyst
$26.80 /

-0.34 (-1.25%)

HCAT Health Catalyst
$26.80 /

-0.34 (-1.25%)

05/27/20 Piper Sandler
Piper bullish on post pandemic opportunities for Health Catalyst
05/15/20
Fly Intel: Top five analyst initiations
05/15/20 Guggenheim
Guggenheim sees Health Catalyst at attractive entry point, starts at Buy
05/15/20 Guggenheim
Health Catalyst initiated with a Buy at Guggenheim
HCAT Health Catalyst
$26.80 /

-0.34 (-1.25%)

HCAT Health Catalyst
$26.80 /

-0.34 (-1.25%)

Recommendations
Piper bullish on post pandemic opportunities for Health Catalyst » 05:18
05/27/20
05/27
05:18
05/27/20
05:18
HCAT

Health Catalyst

$27.38 /

-0.95 (-3.35%)

Piper Sandler analyst…

Piper Sandler analyst Sean Wieland reiterates an Overweight rating on Health Catalyst with a $50 price target after hosting virtual meetings with management. COVID-19 underscores the need for the country's healthcare data management and analytics infrastructure to, in essence, "grow up," Wieland tells investors in a research note. The analyst believes Health Catalyst's data and analytics helped health systems survive COVID-19 and that the platform "is defining the path to recovery." Wieland is bullish on the company's opportunities post the pandemic.

ShowHide Related Items >><<
HCAT Health Catalyst
$27.38 /

-0.95 (-3.35%)

HCAT Health Catalyst
$27.38 /

-0.95 (-3.35%)

05/15/20
Fly Intel: Top five analyst initiations
05/15/20 Guggenheim
Guggenheim sees Health Catalyst at attractive entry point, starts at Buy
05/15/20 Guggenheim
Health Catalyst initiated with a Buy at Guggenheim
05/13/20 RBC Capital
Health Catalyst price target raised to $34 from $30 at RBC Capital
HCAT Health Catalyst
$27.38 /

-0.95 (-3.35%)

HCAT Health Catalyst
$27.38 /

-0.95 (-3.35%)

Conference/Events
Health Catalyst management to meet virtually with Piper Sandler » 07:32
05/21/20
05/21
07:32
05/21/20
07:32
HCAT

Health Catalyst

$28.76 /

+0.17 (+0.59%)

Virtual Meeting to be…

Virtual Meeting to be held on May 21 hosted by Piper Sandler.

ShowHide Related Items >><<
HCAT Health Catalyst
$28.76 /

+0.17 (+0.59%)

HCAT Health Catalyst
$28.76 /

+0.17 (+0.59%)

05/15/20
Fly Intel: Top five analyst initiations
05/15/20 Guggenheim
Guggenheim sees Health Catalyst at attractive entry point, starts at Buy
05/15/20 Guggenheim
Health Catalyst initiated with a Buy at Guggenheim
05/13/20 RBC Capital
Health Catalyst price target raised to $34 from $30 at RBC Capital
HCAT Health Catalyst
$28.76 /

+0.17 (+0.59%)

HCAT Health Catalyst
$28.76 /

+0.17 (+0.59%)

Initiation
Fly Intel: Top five analyst initiations » 10:07
05/15/20
05/15
10:07
05/15/20
10:07
GO

Grocery Outlet

$38.34 /

+0.72 (+1.91%)

, PAE

PAE

$9.41 /

+0.28 (+3.07%)

, PHR

Phreesia

$26.24 /

+0.37 (+1.43%)

, HCAT

Health Catalyst

$28.30 /

+0.37 (+1.32%)

, WIX

Wix.com

$191.93 /

+2.54 (+1.34%)

, CMS

CMS Energy

$53.78 /

-0.55 (-1.01%)

, BEP

Brookfield Renewable

$46.50 /

-0.88 (-1.86%)

Catch up on today's…

Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Grocery Outlet (GO) initiated with a Buy at Goldman Sachs. 2. PAE (PAE) initiated with a Buy at Deutsche Bank. 3. Phreesia (PHR) and Health Catalyst (HCAT) were initiated with a Buy at Guggenheim. 4. Wix.com (WIX) initiated with an Outperform at JMP Securities. 5. CMS Energy (CMS) and Brookfield Renewable (BEP) were initiated with a Neutral at Mizuho. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.

ShowHide Related Items >><<
WIX Wix.com
$191.93 /

+2.54 (+1.34%)

PHR Phreesia
$26.24 /

+0.37 (+1.43%)

PAE PAE
$9.41 /

+0.28 (+3.07%)

HCAT Health Catalyst
$28.30 /

+0.37 (+1.32%)

GO Grocery Outlet
$38.34 /

+0.72 (+1.91%)

CMS CMS Energy
$53.78 /

-0.55 (-1.01%)

BEP Brookfield Renewable
$46.50 /

-0.88 (-1.86%)

GO Grocery Outlet
$38.34 /

+0.72 (+1.91%)

05/15/20 Goldman Sachs
Grocery Outlet initiated with a Buy at Goldman Sachs
01/29/20
Fly Intel: Top five analyst initiations
01/29/20 Craig-Hallum
Grocery Outlet initiated with a Buy at Craig-Hallum
11/12/19 Jefferies
Grocery Outlet comps remain well above industry trend, says Jefferies
PAE PAE
$9.41 /

+0.28 (+3.07%)

05/15/20 Deutsche Bank
Deutsche starts PAE at Buy on 'recession-resilient' government budgets
05/14/20 Deutsche Bank
PAE initiated with a Buy at Deutsche Bank
05/05/20
Fly Intel: Top five analyst initiations
05/05/20 Benchmark
Benchmark starts PAE at Buy with $13 price target
PHR Phreesia
$26.24 /

+0.37 (+1.43%)

05/15/20 Guggenheim
Guggenheim starts 'disproportionately penalized' Phreesia at Buy with $31 target
05/15/20 Guggenheim
Phreesia initiated with a Buy at Guggenheim
04/23/20 Piper Sandler
Market to ultimately reward Phreesia response to pandemic, says Piper Sandler
04/20/20 RBC Capital
Phreesia initiated with a Sector Perform at RBC Capital
HCAT Health Catalyst
$28.30 /

+0.37 (+1.32%)

05/15/20 Guggenheim
Guggenheim sees Health Catalyst at attractive entry point, starts at Buy
05/15/20 Guggenheim
Health Catalyst initiated with a Buy at Guggenheim
05/13/20 RBC Capital
Health Catalyst price target raised to $34 from $30 at RBC Capital
05/13/20 Raymond James
Health Catalyst price target lowered to $40 from $46 at Raymond James
WIX Wix.com
$191.93 /

+2.54 (+1.34%)

05/15/20
Fly Intel: Top five analyst upgrades
05/15/20 Northland
Wix.com price target raised to $200 from $160 at Northland
05/15/20 JPMorgan
Wix.com price target raised to $185 from $149 at JPMorgan
05/15/20 Needham
Wix.com price target raised to $220 from $165 at Needham
CMS CMS Energy
$53.78 /

-0.55 (-1.01%)

05/15/20 Barclays
Barclays upgrades Utilities sector along with PG&E and two others
05/15/20 Barclays
CMS Energy upgraded to Overweight from Equal Weight at Barclays
05/14/20 Mizuho
CMS Energy initiated with a Neutral at Mizuho
04/24/20 Morgan Stanley
Federal support for renewables could come in summer, says Morgan Stanley
BEP Brookfield Renewable
$46.50 /

-0.88 (-1.86%)

05/14/20 Mizuho
Brookfield Renewable initiated with a Neutral at Mizuho
03/31/20 TD Securities
Brookfield Renewable upgraded to Buy with $52 target at TD Securities
03/31/20 TD Securities
Brookfield Renewable upgraded to Buy from Hold at TD Securities
03/20/20 Industrial Alliance
Brookfield Renewable upgraded to Strong Buy from Hold at Industrial Alliance
WIX Wix.com
$191.93 /

+2.54 (+1.34%)

PHR Phreesia
$26.24 /

+0.37 (+1.43%)

HCAT Health Catalyst
$28.30 /

+0.37 (+1.32%)

GO Grocery Outlet
$38.34 /

+0.72 (+1.91%)

CMS CMS Energy
$53.78 /

-0.55 (-1.01%)

BEP Brookfield Renewable
$46.50 /

-0.88 (-1.86%)

CMS CMS Energy
$53.78 /

-0.55 (-1.01%)

WIX Wix.com
$191.93 /

+2.54 (+1.34%)

PHR Phreesia
$26.24 /

+0.37 (+1.43%)

HCAT Health Catalyst
$28.30 /

+0.37 (+1.32%)

GO Grocery Outlet
$38.34 /

+0.72 (+1.91%)

WIX Wix.com
$191.93 /

+2.54 (+1.34%)

PHR Phreesia
$26.24 /

+0.37 (+1.43%)

GO Grocery Outlet
$38.34 /

+0.72 (+1.91%)

Initiation
Guggenheim sees Health Catalyst at attractive entry point, starts at Buy » 09:20
05/15/20
05/15
09:20
05/15/20
09:20
HCAT

Health Catalyst

$27.93 /

-0.34 (-1.20%)

As previously reported,…

As previously reported, Guggenheim analyst Glen Santangelo initiated coverage of Health Catalyst with a Buy rating and $33 price target. He sees the company's "compelling value proposition to customers" as one that should resonate well over the long-term, although he appreciates the near-term disruption in end-market purchasing driven by COVID-19, Santangelo stated. Near-term challenges are now largely embedded in investor expectations and he expects the focus to begin to shift toward FY21, adding that he believes consensus expectations are "at an achievable level" and that current shares levels offer an attractive entry point.

ShowHide Related Items >><<
HCAT Health Catalyst
$27.93 /

-0.34 (-1.20%)

HCAT Health Catalyst
$27.93 /

-0.34 (-1.20%)

05/15/20 Guggenheim
Health Catalyst initiated with a Buy at Guggenheim
05/13/20 RBC Capital
Health Catalyst price target raised to $34 from $30 at RBC Capital
05/13/20 Raymond James
Health Catalyst price target lowered to $40 from $46 at Raymond James
04/20/20 RBC Capital
Health Catalyst initiated with an Outperform at RBC Capital
HCAT Health Catalyst
$27.93 /

-0.34 (-1.20%)

HCAT Health Catalyst
$27.93 /

-0.34 (-1.20%)

Initiation
Health Catalyst initiated with a Buy at Guggenheim » 06:10
05/15/20
05/15
06:10
05/15/20
06:10
HCAT

Health Catalyst

$27.93 /

-0.34 (-1.20%)

Guggenheim analyst Glen…

Guggenheim analyst Glen Santangelo initiated coverage of Health Catalyst with a Buy rating and $33 price target.

ShowHide Related Items >><<
HCAT Health Catalyst
$27.93 /

-0.34 (-1.20%)

HCAT Health Catalyst
$27.93 /

-0.34 (-1.20%)

05/13/20 RBC Capital
Health Catalyst price target raised to $34 from $30 at RBC Capital
05/13/20 Raymond James
Health Catalyst price target lowered to $40 from $46 at Raymond James
04/20/20 RBC Capital
Health Catalyst initiated with an Outperform at RBC Capital
04/20/20 Cantor Fitzgerald
Health Catalyst price target lowered to $44 from $47 at Cantor Fitzgerald
HCAT Health Catalyst
$27.93 /

-0.34 (-1.20%)

HCAT Health Catalyst
$27.93 /

-0.34 (-1.20%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.